C WorldWide Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-37,392
Closed -$4.26M 122
2019
Q1
$4.26M Sell
37,392
-4,232
-10% -$311K 0.05% 65
2018
Q4
$1.63M Sell
41,624
-13,375
-24% -$580K 0.02% 86
2018
Q3
$3M Buy
54,999
+3,403
+7% +$233K 0.04% 83
2018
Q2
$4.27M Buy
51,596
+9,822
+24% +$758K 0.06% 72
2018
Q1
$2.78M Sell
41,774
-6,277
-13% -$362K 0.04% 75
2017
Q4
$2.47M Sell
48,051
-4,298
-8% -$309K 0.04% 78
2017
Q3
$4.67M Buy
52,349
+68
+0.1% +$5.16K 0.07% 65
2017
Q2
$3.12M Buy
52,281
+7,449
+17% +$416K 0.05% 77
2017
Q1
$2.39M Sell
44,832
-10,834
-19% -$643K 0.04% 83
2016
Q4
$2.78M Sell
55,666
-10,134
-15% -$543K 0.05% 68
2016
Q3
$3.95M Sell
65,800
-1,600
-2% -$92.2K 0.07% 62
2016
Q2
$3.45M Sell
67,400
-13,000
-16% -$555K 0.07% 54
2016
Q1
$2.37M Buy
80,400
+1,780
+2% +$56.1K 0.05% 64
2015
Q4
$3.56M Buy
78,620
+1,400
+2% +$73.4K 0.06% 65
2015
Q3
$3.22M Buy
77,220
+15,220
+25% +$794K 0.05% 71
2015
Q2
$3.74M Buy
62,000
+25,000
+68% +$1.65M 0.05% 71
2015
Q1
$2.87M Buy
+37,000
New +$2.13M 0.04% 72

Other funds holding ONCE

C WorldWide Group's ONCE Position: Q2 2019 in Review

C WorldWide Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 37,392 shares — an estimated $4.26M sold.

C WorldWide Group first reported a position in ONCE in Q1 2015 and held it in 17 quarters. The position peaked at $4.67M in Q3 2017. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • C WorldWide Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 37,392 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $4.26M.
  • C WorldWide Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 17 quarters.
  • C WorldWide Group's Spark Therapeutics, Inc. Common Stock position peaked at $4.67M in Q3 2017.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.